PTC Therapeutics, Inc. (PTCT) /

The profitability of PTC Therapeutics, Inc. over the past 10 years

Chart PTC Therapeutics, Inc.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

PTC Therapeutics, Inc. reported net income of $682.64M in fiscal 2025, the latest fiscal year on file. That year it had operating income of $866.93M. It reported a profit in 1 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 and 2024.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025—$866.93M$682.64M
2024ended Dec 31, 2024—-$302.57M-$363.3M
2023ended Dec 31, 2023—-$439.5M-$626.6M
2022ended Dec 31, 2022—-$447.41M-$559.02M
2021ended Dec 31, 2021—-$374.44M-$523.9M
2020ended Dec 31, 2020—-$431.77M-$438.16M
2019ended Dec 31, 2019$294.85M*-$241.16M-$251.58M
2018ended Dec 31, 2018$252.06M*-$115.69M-$128.08M
2017ended Dec 31, 2017$189.81M*-$64.29M-$79M
2016ended Dec 31, 2016$82.7M*-$132.06M-$142.11M

Fiscal years as PTC Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on PTC Therapeutics, Inc.

Companies of a similar size

Not investment advice. This page shows what PTC Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.